Confirm the amount in the vial (commonly 5 mg or 10 mg)
Zibotentan is an antagonist targeting the ETA receptor and is currently undergoing Phase 2 clinical development for the treatment of portal hypertension, cirrhosis, albuminuria, type 2 diabetes, chronic kidney disease, liver disease, and more
Miederer, S.E
Cell were then treated with Cy5.5-labeled NP4 for 1 h, 4 h, or 7 h, respectively, washed with PBS, and analyzed by flow cytometry (Beckman Coulter, U.S.A.)
Composition Melanotan 2 (10mg): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis of ghrelin-pathway models Chromatographic method optimization for impurity profiling and peak resolution Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Enjoy attractive offers on ayurvedic medicines and products at affordable prices and customer demand, suitable to everyones pocket